8-K: Chemung Financial Reports Strategic Balance Sheet Repositioning, Anticipates Q2 Loss Amidst Long-Term Profitability Push

Chemung Financial Corporation's banking subsidiary completed a strategic sale of $242 million in securities, incurring a $17 million pre-tax loss in Q2 2025, but expects long-term benefits to profitability and capital levels.

Summary

• Chemung Canal Trust Company, a wholly-owned banking subsidiary of Chemung Financial Corporation, completed a strategic balance sheet repositioning.
• The repositioning involved selling available-for-sale securities with a book value of approximately $242 million.
• The securities sold had a weighted average book yield of approximately 2.1% and a weighted average life of approximately three years.
• The sale resulted in a pre-tax realized loss of approximately $17 million, which will be recognized in the Corporation's second quarter 2025 financial results.
• This transaction was executed in conjunction with the Corporation's previously announced issuance of $45.0 million in 7.75% Fixed-to-Floating Rate Subordinated Notes due 2035, completed on June 10, 2025.
• The subordinated notes were issued via private placement to accredited investors and qualified institutional buyers, intended to qualify as Tier 2 capital.
• The Corporation expects to report a net loss for the second quarter of 2025 as a result of this transaction.
• Proceeds from the securities sale are intended to reduce higher-cost non-core funding liabilities and support organic loan growth, particularly in targeted expansion markets.
• The transaction will not impact shareholders' equity or book value per share as of the sale date, as unrealized losses on available-for-sale securities were already accounted for.
• At March 31, 2025, the Bank's Tier 1 Capital to risk-weighted assets ratio was 12.11%.
• The net effect of the securities sale and the downstreaming of subordinated notes proceeds is expected to increase Tier 1 Capital levels at the Bank, which remains well capitalized.

Sentiment

Score: 7

Explanation: While there is an immediate negative impact of a $17 million pre-tax loss and an expected net loss for Q2 2025, the strategic rationale behind the balance sheet repositioning is positive. The transaction is expected to yield favorable impacts on net income, net interest margin, and returns starting in Q3 2025, improve capital levels, and support organic loan growth. The short-term pain is for long-term gain.

Positives

• The transaction is expected to have a favorable impact on the Corporation's net income, net interest margin, return on average assets, and return on average equity starting in the third quarter of 2025.
• Proceeds from the securities sale will be used to reduce higher-cost non-core funding liabilities, improving cost efficiency.
• The proceeds will also support organic loan growth, particularly in targeted expansion markets, indicating strategic growth initiatives.
• The net effect of the securities sale and subordinated notes issuance is expected to increase Tier 1 Capital levels at the Bank, strengthening its capital position.
• The Bank remains well capitalized under applicable regulatory guidelines following these transactions.

Negatives

• The sale of available-for-sale securities resulted in a significant pre-tax realized loss of approximately $17 million.
• The Corporation expects to report a net loss for the second quarter of 2025 due to this transaction.

Risks

• Changes in economic conditions or interest rates.
• Credit risk.
• Inflation.
• Tariffs.
• Cybersecurity risks.
• Changes in FDIC assessments.
• Bank failures.
• Difficulties in managing the Corporation's growth.
• Competition.
• Changes in law or the regulatory environment.
• Changes in general business and economic trends.

Future Outlook

The Corporation expects to report a net loss for the second quarter of 2025 due to the securities sale. However, beginning in the third quarter of 2025, this strategic transaction is anticipated to have a favorable impact on the Corporation's net income, net interest margin, return on average assets, and return on average equity. The proceeds from the sale are intended to reduce higher-cost funding and support organic loan growth, particularly in targeted expansion markets. The Bank's Tier 1 Capital levels are expected to increase, and it will remain well capitalized.

Management Comments

• The transaction was completed in conjunction with the Corporation's previously announced issuance of $45.0 million in aggregate principal amount of 7.75% Fixed-to-Floating Rate Subordinated Notes due 2035, completed on June 10, 2025.
• The Corporation expects to report a net loss for the second quarter of 2025 as a result of this transaction.
• Proceeds from the securities sale are expected to be used to reduce higher-cost non-core funding liabilities and support organic loan growth, particularly in the Corporation's targeted expansion markets.
• The transaction will have no impact on shareholders equity or book value per share as of the date of the sale, as unrealized losses on available-for-sale securities are already accounted for as a deduction to shareholders equity.
• Following these transactions, the Bank remains well capitalized under applicable regulatory guidelines.
• Beginning in the third quarter of 2025, this transaction is expected to have a favorable impact on the Corporation's net income, net interest margin, return on average assets, and return on average equity.

Industry Context

This balance sheet repositioning by Chemung Financial Corporation reflects a broader trend in the banking industry where institutions are actively managing their asset and liability structures in response to evolving interest rate environments and funding costs. By selling lower-yielding securities and using the proceeds to reduce higher-cost liabilities and fund loan growth, the bank aims to improve its net interest margin and overall profitability. The issuance of subordinated notes to bolster Tier 2 capital is also a common strategy for banks seeking to optimize their capital structure and support future growth while maintaining strong regulatory capital ratios.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or results to assess the outcomes against global benchmarks. The strategic repositioning is a company-specific decision aimed at optimizing its balance sheet given its unique asset mix and funding costs.
• The reported Tier 1 Capital to risk-weighted assets ratio of 12.11% (as of March 31, 2025) indicates a strong capital position, generally above the minimum regulatory requirements for 'well capitalized' institutions (typically 8% for Tier 1 Capital).

Stakeholder Impact

• Shareholders: Will experience a short-term negative impact with an expected net loss in Q2 2025, but are expected to benefit from improved profitability (net income, NIM, ROAA, ROAE) starting in Q3 2025.
• Customers: May benefit from increased availability of funds for organic loan growth, particularly in targeted expansion markets.
• Creditors (Subordinated Note Holders): Will receive 7.75% Fixed-to-Floating Rate interest payments until 2035.

Next Steps

• Recognition of the $17 million pre-tax realized loss in the Corporation's second quarter 2025 financial results.
• Reporting of a net loss for the second quarter of 2025.
• Utilization of proceeds from the securities sale to reduce higher-cost non-core funding liabilities.
• Utilization of proceeds from the securities sale to support organic loan growth, particularly in targeted expansion markets.
• Realization of favorable impact on net income, net interest margin, return on average assets, and return on average equity beginning in the third quarter of 2025.

Key Dates

Recommendation

Keywords

Chemung Financial Corporation, SEC filing, 8-K, balance sheet repositioning, securities sale, available-for-sale securities, pre-tax loss, subordinated notes, Tier 2 capital, net interest margin, return on average assets, return on average equity, banking, financial services, capital management, loan growth